Abstract:Bioaccessibility to assess potential risks resulting from exposure to Pb-contaminated soils is commonly estimated using various in vitro methods. However, existing in vitro methods yield different results depending on the composition of the extractant as well as the contaminated soils. For this reason, the relationships between the five commonly used in vitro methods, the Relative Bioavailability Leaching Procedure (RBALP), the unified BioAccessibility Research Group Europe (BARGE) method (UBM), the Solubility Bioaccessibility Research Consortium assay (SBRC), a Physiologically Based Extraction Test (PBET), and the in vitro Digestion Model (RIVM) were quantified statistically using 10 soils from long-term Pb-contaminated mining and smelter sites located in Western Australia and South Australia. For all 10 soils, the measured Pb bioaccessibility regarding all in vitro methods varied from 1.9 to 106 % for gastric phase, which is higher than that for intestinal phase: 0.2 ∼ 78.6 %. The variations in Pb bioaccessibility depend on the in vitro models being used, suggesting that the method chosen for bioaccessibility assessment must be validated against in vivo studies prior to use for predicting risk. Regression studies between RBALP and SRBC, RBALP and RIVM (0.06) (0.06 g of soil in each tube, S:L ratios for gastric phase and intestinal phase are 1:375 and 1:958, respectively) showed that Pb bioaccessibility based on the three methods were comparable. Meanwhile, the slopes between RBALP and UBM, RBALP and RIVM (0.6) (0.6 g soil in each tube, S:L ratios for gastric phase and intestinal phase are 1:37.5 and 1:96, respectively) were 1.21 and 1.02, respectively. The findings presented in this study could help standardize in vitro bioaccessibility measurements and provide a scientific basis for further relating Pb bioavailability and soil properties.

An Interlaboratory Evaluation of the Variability in Arsenic and Lead Relative Bioavailability when Assessed Using a Mouse Bioassay.

Arsenic Relative Bioavailability in Contaminated Soils: Comparison of Animal Models, Dosing Schemes, and Biological End Points

As, Cd, and Pb Relative Bioavailability in Contaminated Soils: Coupling Mouse Bioassay with UBM Assay.

Lead Relative Bioavailability in Soils Based on Different Endpoints of a Mouse Model.

Oral Bioavailability of As, Pb, and Cd in Contaminated Soils, Dust, and Foods based on Animal Bioassays: a Review.

Evaluating the mouse model for estimation of arsenic bioavailability: Comparison of estimates of absolute bioavailability of inorganic arsenic in mouse, humans, and other species

Variation of lead bioaccessibility in soil reference materials: Intra- and inter-laboratory assessments

Arsenic Relative Bioavailability in Rice Using A Mouse Arsenic Urinary Excretion Bioassay and Its Application to Assess Human Health Risk

Assessment of relative bioavailability of heavy metals in soil using in vivo mouse model and its implication for risk assessment compared with bioaccessibility using in vitro assay.

Variability associated with as in vivo-in vitro correlations when using different bioaccessibility methodologies

A Pooled Data Analysis To Determine The Relationship Between Selected Metals And Arsenic Bioavailability In Soil

In Vitro Bioaccessibility and in Vivo Relative Bioavailability in 12 Contaminated Soils: Method Comparison and Method Development

Antagonistic Interactions Between Arsenic, Lead, and Cadmium in the Mouse Gastrointestinal Tract and Their Influences on Metal Relative Bioavailability in Contaminated Soils.

Correlation of in Vivo Relative Bioavailability to in Vitro Bioaccessibility for Arsenic in Household Dust from China and Its Implication for Human Exposure Assessment.

Nickel oral bioavailability in contaminated soils using a mouse urinary excretion bioassay: Variation with bioaccessibility

Arsenic, lead, and cadmium bioaccessibility in contaminated soils: Measurements and validations

Comparison of in Vitro Models in a Mice Model and Investigation of the Changes in Pb Speciation During Pb Bioavailability Assessments.

Assessment of four commonly employed in vitro arsenic bioaccessibility assays for predicting in vivo relative arsenic bioavailability in contaminated soils

Lead bioaccessibility in 12 contaminated soils from China: Correlation to lead relative bioavailability and lead in different fractions.

Using the SBRC Assay to Predict Lead Relative Bioavailability in Urban Soils: Contaminant Source and Correlation Model.

Quantifying statistical relationships between commonly used in vitro models for estimating lead bioaccessibility